Dna X (SONM) Asset Writedowns and Impairment (2018 - 2025)

Dna X (SONM) has 7 years of Asset Writedowns and Impairment data on file, last reported at $984000.0 in Q4 2025.

• Quarterly Asset Writedowns and Impairment rose 142.23% year-over-year to $984000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$262000.0 (down 129.44% YoY) and the FY2025 annual result came in at $2.1 million, up 133.15% from the prior year.
• Asset Writedowns and Impairment retreated to $984000.0 in Q4 2025, from $1.1 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $3.2 million in Q2 2024 to a low of -$2.3 million in Q4 2024.
• A 4-year average of $574875.0 and a median of $819500.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment soared 6892.31% — and 2022, when it tumbled 99.67%.
• Tracing SONM's Asset Writedowns and Impairment over 4 years: stood at $909000.0 in 2021, then plunged by 99.67% to $3000.0 in 2022, then sank by 77766.67% to -$2.3 million in 2024, then jumped by 142.23% to $984000.0 in 2025.
• The last three Asset Writedowns and Impairment figures came in at $984000.0 (Q4 2025), $1.1 million (Q2 2025), and -$2.3 million (Q4 2024), per Business Quant data.